4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-033290
Chief Executive Officer acquired 49,448 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2019-05-24 | Option exercise | +40,072 | $2.01 | $80,545 | 2,132,527 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2019-05-24 | Option exercise | +9,376 | $2.62 | $24,565 | 2,141,903 | D |
| Derivatives | |||||||
| Anzalone Christopher Richard Chief Executive Officer | 2019-05-24 | Option exercise · Stock Option (right to buy) | −40,072 | 1,142,794 | D | ||
| Anzalone Christopher Richard Chief Executive Officer | 2019-05-24 | Option exercise · Stock Option (right to buy) | −9,376 | 1,133,418 | D | ||
Loading xslF345X03/doc4.xml…